KLOW (Blend)

Storing Four Peptides Under One Set of Conditions

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

KLOW is stored lyophilised, cold, dry and protected from light. Light protection is required because of the copper complex. No reducing agent is needed, because none of the four components contains cysteine. TB-500, as full-length thymosin beta-4, carries one methionine that copper could oxidise, which is one more reason for cold, dry, dark storage.

Key facts

Storage
Lyophilised, cold, dry, dark
Light protection
Required (copper complex)
Reducing agent
Not needed (no cysteine present)
Chelator
Not needed (no oxidation substrate)
Governing component
The most sensitive of four
Freeze-thaw
Aliquot before freezing

One condition for four compounds

The four KLOW blend peptides share one vial and one storage environment, and the most sensitive component determines it for all of them. There is no way to give one gentler treatment than another, which is the storage expression of the same inseparability that fixes the ratio.

What requires the light protection

The copper complex. Metal complexes are generally light-sensitive and copper is redox-active, so this is a substantive requirement rather than a generic instruction. The other three components would tolerate more; in this vial they get the copper complex's conditions.

Research material referenced

KLOW 80mg, third-party HPLC tested

Buy KLOW · £79.99

What is not needed, and why

No reducing agent. Copper catalyses oxidation of cysteine thiols and methionine thioethers. None of KPV, BPC-157 or TB-500 contains cysteine, so the thiol reaction has no substrate. TB-500, as full-length thymosin beta-4, does carry one methionine, the one residue in the vial copper could oxidise. That is a specific chemical fact about this particular combination rather than a general property of blends.

The asymmetry to be aware of

Surface adsorption affects the smallest component most, so KPV is disproportionately lost to glass and plastic at low concentrations. That loss changes the effective ratio silently, and it is not captured by any storage instruction or certificate figure. Low-binding consumables and minimal transfers are the practical response.

After reconstitution

Once a KLOW vial is reconstituted, four peptides each follow their own solution stability. The least stable governs the useful life of the whole preparation, since none can be used separately once combined. Aliquot into single-use volumes before freezing rather than cycling a stock: freeze-thaw damages all four and there is no selective recovery.

Frequently asked questions

Does the copper require a chelator?

No chelator is part of the storage advice. None of the four components contains cysteine; the one residue copper could oxidise is TB-500's methionine, which is why the vial is kept cold, dry and dark.

Why is light protection required?

The copper complex. Metal complexes are generally light-sensitive and copper is redox-active.

How long does it last once reconstituted?

The least stable of the four governs, since none can be used separately once combined.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More KLOW (Blend) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.